Immunotherapy for Alzheimer’s disease shows promise in mouse study
Activation of immune cells called microglia with an antibody reduces amyloid plaques in the brain and mitigates behavioral abnormalities in mice with Alzheimer’s-like disease. …
Activation of immune cells called microglia with an antibody reduces amyloid plaques in the brain and mitigates behavioral abnormalities in mice with Alzheimer’s-like disease. …
Daily aspirin use is inexpensive and could reduce cardiovascular deaths globally, but fewer than half of people worldwide who have had a heart attack or stroke take the medication. …
A randomized controlled trial found that two commonly used anti-inflammatory drugs did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone. …
The gut microbiomes of people with pre-symptomatic Alzheimer’s disease have different composition than that of healthy individuals. …
Researchers have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. …
Dangerous bacterial bloodstream infections in preemies may originate from the infants’ gut microbiomes. …
A phase 3 clinical trial has shown that a combination of the investigational drug motixafortide with standard therapy increases the number of stem cells harvested from multiple myeloma patients. …
New research suggests that updated COVID-19 vaccine booster shots will be important for shoring up population immunity as new variants emerge. …
A new study indicates that microglia, the brain’s resident immune cells, partner with T cells to cause neurodegeneration in Alzheimer’s related diseases. …
New research suggests that cancer patients who respond to immunotherapy may have more CD5+ dendritic cells in their tumors. …
End of content
End of content